November 21st 2024
Coverage from the recent Institute for Value-Based Medicine event with NYU Langone Health.
November 20th 2024
Delve into the current state of prescription digital therapeutics (PDTs) adoption and uncover strategies for increasing payer approval and achieving widespread coverage of PDTs.
Dr Susan Escudier Discusses Uptake of Digital Health Solutions at Texas Oncology
July 22nd 2022The use of digital health solutions has been a tremendous benefit during the pandemic that should continue, said Susan Escudier, MD, FACP, vice president, value-based care and quality programs, Texas Oncology.
Watch
CGM for Diabetes on the Rise in Italy, but Usage Is Still Lower Than Expected, Study Says
July 22nd 2022Children with type 1 diabetes had the highest rates of using continuous glucose monitoring and continuous subcutaneous insulin infusion in Italy, according to recent research, but economic barriers prevent widespread adoption.
Read More
Using AI to Screen for Preventable Infant Blindness in Underresourced Countries
July 18th 2022A recent study examined whether an artificial intelligence (AI) trained risk model could screen for retinopathy of prematurity, a leading cause of preventable blindness in infants in low- and middle-income countries, via telehealth.
Read More
Contributor: Charting a New Path to At-Home Medication Adherence With Digital Pharmacy Support
July 17th 2022Polypharmacy and medication adherence are common problems among the Medicare patient population, and this article addresses how Medicare Advantage plans can address these challenges and improve patient outcomes.
Read More
Patients Lost to Follow-up and Perspectives on Telehealth for Retinal Disease During COVID-19
July 17th 2022Two posters presented at the American Society of Retina Specialists 40th Annual Scientific Meeting evaluated the impact of the COVID-19 pandemic on rates of patients lost to follow-up and patient perspectives regarding telehealth for retinal disease.
Read More
Predicting Visual Outcomes and Visual Improvement in Macular Edema Due to CRVO
July 16th 2022A machine learning model was able to predict visual outcomes and showed that the time from diagnosis to first treatment indicates visual improvement in patients with macular edema due to central retinal vein occlusion (CRVO).
Read More
Technology Allows for Earlier Detection of Eye Conditions
July 15th 2022Although technology is allowing for earlier detection of eye conditions, lack of reimbursement and insurance coverage remain major barriers to widespread use, explained speakers at the American Society of Retina Specialists 40th Annual Scientific Meeting.
Read More
Transformative Technology Is Driving Change in Retina Care Delivery
July 15th 2022The retina space is evolving due to new technology that is changing the way specialists deliver care, whether that means offering the ability to do new procedures in the office or providing more virtual or hybrid care.
Read More
Telerehabilitation Reduces Pain, Improves Function for People With Musculoskeletal Needs
July 10th 2022Participants in a digital acute musculoskeletal (MSK) program experienced better pain and function outcomes vs nonparticipants, demonstrating benefits for acute and subacute MSK conditions.
Read More
Contributor: Technology, Supplemental Services in MA Can Help Improve Participant Health
July 10th 2022Social determinants of health present many health-related challenges for Medicare Advantage (MA) plan members, something these plans are looking to overcome by diversifying their service offerings.
Read More
Dr Debra Patt Highlights the High Usage of Digital Health Solutions at Texas Oncology
July 3rd 2022Digital health care has been a key initiative at Texas Oncology, because it ensure patients can receive better care at their home, explained Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology.
Watch
There Is More to Blame Than Tech for T1D Outcomes Disparities, Investigators Argue
June 21st 2022Investigators from the Pediatric Diabetes Center at Hassenfeld Children’s Hospital at NYU Langone investigated outcomes disparities as they related to diabetes technology use among youth living with type 1 diabetes (T1D).
Read More
Dr Debra Patt: Telemedicine’s Contribution to Cancer Care Robust and Meaningful
June 20th 2022Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, discusses how enhancements to telemedicine precipitated by the COVID-19 pandemic have made lasting and meaningful changes to oncology care, including that these care improvements will persist post pandemic.
Watch
Artificial Intelligence “Twin” Technology Improves Remission Rates for T2D
June 12th 2022A wearable device powered by artificial intelligence and the Internet of Things to create a "digital twin" reduced glycated hemoglobin and improved remission rates for patients with type 2 diabetes (T2D) through personalized care.
Read More
AI Holds Potential to Support Ethical Principles in Hematology—but There’s a Dark Side
June 11th 2022During a session at the 2022 European Hematology Association Congress, speakers discussed how artificial intelligence (AI) can help advance the principles of ethical medicine—but also how new technologies are being used to undermine the integrity of scientific research.
Read More
Dr Ravi Parikh Offers Solutions to Barriers During Shift From Fee-for-Service to APMs
June 10th 2022Designing rational spending targets and having small sample sizes are 2 main challenges payers and partners face in the shift toward alternative payment models (APMs), said Ravi B. Parikh, MD, MPP, assistant professor of medical ethics and health policy, assistant professor of medicine, University of Pennsylvania.
Watch
Combining Techniques Boosts Diagnostic Sensitivity in Intrahepatic Cholangiocarcinoma
June 9th 2022Hepatobiliary-phase enhanced imaging outperformed diffusion-weighted imaging in distinguishing intrahepatic mass-forming cholangiocarcinoma, but the accuracy is greater when these methods are used in tandem.
Read More
CREATE Trial Data Add to Support of Open-Source AID Use in T1D
June 9th 2022Findings presented at the 82nd Scientific Sessions of the American Diabetes Association support the safety and efficacy of open-source automated insulin delivery (AID) systems among children and adults living with type 1 diabetes (T1D).
Read More
Sacubitril/Valsartan Reduces mPAP, Improves Functional Capacity in HFpEF-PH
June 3rd 2022Sacubitril/valsartan reduced mean pulmonary artery pressure (mPAP) and improved lung congestion, functional capacity, and quality of life in a subset of patients with heart failure with preserved ejection fraction and pulmonary hypertension (HFpEF-PH) using a remote monitoring platform.
Read More